There’s a piece of math from inside our studio that changes how most MedTech marketing leaders think about their content budget.
One of our clients is on a retainer with us for a little over $5,000 a month. The volume of content we’re producing for that engagement, social calendars, posts, blog articles, worksheets, sales enablement content, website assets, would have cost $30,000 to $40,000 to produce before AI. At least.
Better quality. At a fraction of the price.
That’s not a projection, and it’s not a vendor pitch. It’s our current production reality, running every day across our client retainers. And it means something uncomfortable for any medical device company still budgeting for content the way the industry did in 2019: you’re paying for a workflow that no longer needs to exist.
This article covers how AI content for MedTech actually gets made at that level, where the old budget was leaking, the three tools that power the system, and the one thing you should absolutely still be paying for.
Where MedTech content budgets were leaking
For most device companies, the biggest content costs were never the finished films or the polished launch assets. The money leaked out of the front end of content production, the part agencies billed as "thinking time":
→ Figuring out what to create in the first place
→ Building the social calendars
→ Writing the individual social posts
→ Drafting the blog articles
→ Producing the worksheets and sales tools
→ Creating assets for your website
All of it billed by the hour, at agency rates, across weeks of back-and-forth. Tens of thousands of dollars in budgetary time, for work that AI now does faster. And honestly, better.
We’ve spent 10+ years working exclusively in MedTech, backed by 30 years of creative direction experience. We have never seen a shift in production economics like this one. The medical device marketing teams that understand it are producing five to eight times the content on the same budget. The ones that don’t are funding their agency’s old workflow.
To be clear about scope: this shift applies to the front end of content production. Finished MOA animations, surgical visualizations, and launch films remain traditional 3D pipeline work, we covered exactly where that line sits in AI in Medical Device Animation: What It Can and Can’t Do. But the everyday content layer that surrounds those hero assets, the layer that used to quietly consume the majority of a MedTech content budget, is where the economics have completely changed.
What you should still be paying for
Here’s where we break from the AI evangelists.
AI is the best associate creative director we’ve ever worked with. It’s fast, it’s tireless, and it’s genuinely creative. But it’s still the associate. It gets you 80% of the way there, and the last 20% is where the work either becomes something you’d put your device’s name on, or it doesn’t.
So the rule is simple: stop paying for drafts. Keep paying for judgment.
You absolutely should be paying for creative talent to oversee the work AI creates for you. Someone with the taste to know which 80% to keep. Someone accountable for clinical accuracy, because "the AI wrote it" is not a defense your regulatory team will accept. In an AI-powered workflow, the creative thinking is the product. The production is the tool.
You can’t dabble with this
MedTech marketing leaders reach out to us all the time asking the same question: "How do we do this? Can you teach us?"
Our answer is always the same: happy to show you. But here’s what we’ve learned building an AI content system for MedTech, this is not something you dabble with. You’re either in or you’re not.
Dabbling gets you quick wins. A post here, a draft there. But if you’re looking to build a real content production system for your organization, one that reliably outputs a month of sales enablement content, social calendars, and articles on a fraction of the old budget, you have to be all in. Learn it, embrace it, and operate it every day. That’s how we run it: daily, on every project, as the production backbone of the studio.
That’s the real gap in the market right now. It’s not the technology and it’s not the budget. It’s that most MedTech marketing teams have no one all-in on operating AI as a production system. And half-in is expensive. It’s the difference between paying $5K and paying $40K for the same output.
The three tools you need to produce AI content at scale
We’re not gatekeeping the stack. The tools were never the moat, the thinking behind them is. Here’s exactly what we run:
1. Claude, set up with Projects.
We’ve used both Claude and ChatGPT extensively. We’ll take Claude any day of the week. The difference isn’t just the writing, it’s the setup. Claude lets you build a project for every workstream, each with its own knowledge base: your product specs, your clinical positioning, your voice, your past content. It’s constantly learning your world, so every piece of content compounds on the last one. You’re never starting from a blank page. You’re starting from everything you’ve already figured out.
2. A voice dictation tool.
This is the sleeper pick, and it may be the most important one. Our team hardly types anymore, we use Wispr Flow, holding down a button and talking, sometimes rambling for minutes straight. Then AI shapes it.
Here’s why that matters for MedTech content specifically: the number one complaint about AI content is that it all sounds the same. It sounds the same because people type generic prompts and get generic output. When the raw material is your voice, your perspective, your clinical knowledge, your actual thinking out loud, the output can’t be generic. Every piece of content in our system starts as a conversation, not a prompt. That’s the guarantee that what gets published carries a real point of view, because it literally started in someone’s voice.
3. Figma, as your content hub.
Figma has become the hub for all of our clients’ content. It’s where collaboration happens, and with the MCP connector between Claude and Figma, we push designs straight into Figma as HTML, built inside each client’s brand system. This is where AI content stops being text in a chat window and becomes finished, on-brand medical device visualization and sales assets.
Most MedTech teams aren’t here yet. That’s exactly why the ones who get here first win.
The whole stack costs a couple hundred dollars a month. What it replaces cost tens of thousands. Set up these three tools, operate them well, and you’re already ahead of most of the industry.
The catch: the stack doesn’t supply the creative direction
Here’s where we see this going wrong every day: MedTech companies leveraging Canva to create content at scale. And their content looks exactly like the next company’s content. Same templates. Same AI-generated visuals. Same everything. They’ve put the templates and the AI in the creative director’s chair, and the result is sameness at scale. Canva is a great tool for a lot of things. Real brand building isn’t one of them.
AI gets you the 80%. The 20%, the taste, the MedTech fluency, the clinical accuracy accountability, the judgment about what actually moves a surgeon or a rep, that’s still human. That’s still what you hire for. Your device isn’t a template. Your content shouldn’t be either.
It’s why we built Vueflow, our Vuelab-managed creative service line: AI-powered content production with a MedTech creative director steering every piece. Our clients get the new economics of AI content for MedTech without gambling on the quality, the $5K-doing-$40K-of-work math, with 30 years of creative direction standing behind every asset.
If you want to see what your current content spend buys versus what it should, let’s talk. We’ll walk you through the real math, including ours: what a modern MedTech content retainer produces month to month, where AI carries the volume, and where the creative direction earns its keep.